Literature DB >> 25667510

Combined treatment of breast cancer cell lines with vitamin D and COX-2 inhibitors.

Marc Thill1, Kathrin Reichert2, Alena Woeste2, Stephan Polack2, Dorothea Fischer2, Friederike Hoellen2, Achim Rody2, Michael Friedrich3, Frank Köster4.   

Abstract

BACKGROUND: Vitamin D is known for its anti-cancerogenous potential. Prostaglandin E2 (PGE2) is a proliferation and inflammation activating agent. The production of PGE2 is dependent on the activity of cyclooxygenase-2 (COX-2). A link between vitamin D and PGE2 metabolism was recently shown.
MATERIALS AND METHODS: In MDA-MB-231 and MCF-7 breast cancer cell lines we investigated the influence of calcitriol and the COX-2 inhibitor celecoxib regarding cell growth via MTT test, as well as on the protein and mRNA expression of COX-2 using western blot and qRT-PCR.
RESULTS: The proliferation of MCF-7 and MDA-MB-231 was inhibited by both calcitriol and the COX-2 inhibitor celecoxib and even stronger by their combination. Moreover, calcitriol inhibited the COX-2 protein expression in MDA-MB-231, as well as the COX-2 mRNA expression in both cell lines.
CONCLUSION: The combination of calcitriol and celecoxib demonstrated a cooperative growth-inhibiting effect in breast cancer cell lines. Copyright
© 2015 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.

Entities:  

Keywords:  Vitamin D; breast cancer; celecoxib; cyclooxygenase-2

Mesh:

Substances:

Year:  2015        PMID: 25667510

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  12 in total

1.  Evaluation of Serum Vitamin D Levels in Adolescents with Pubertal Gynecomastia.

Authors:  Melis Pehlivantürk Kızılkan; Sinem Akgül; Filiz Akbıyık; Orhan Derman; Nuray Kanbur
Journal:  Breast Care (Basel)       Date:  2016-10-13       Impact factor: 2.860

Review 2.  Phytotherapy and Nutritional Supplements on Breast Cancer.

Authors:  C M Lopes; A Dourado; R Oliveira
Journal:  Biomed Res Int       Date:  2017-08-06       Impact factor: 3.411

Review 3.  Influence of vitamin D signaling on hormone receptor status and HER2 expression in breast cancer.

Authors:  Xi Zhang; Nadia Harbeck; Udo Jeschke; Sophie Doisneau-Sixou
Journal:  J Cancer Res Clin Oncol       Date:  2016-12-26       Impact factor: 4.553

4.  Chemical Synthesis and Biological Activities of 20S,24S/R-Dihydroxyvitamin D3 Epimers and Their 1α-Hydroxyl Derivatives.

Authors:  Zongtao Lin; Srinivasa Reddy Marepally; Dejian Ma; Linda K Myers; Arnold E Postlethwaite; Robert C Tuckey; Chloe Y S Cheng; Tae-Kang Kim; Junming Yue; Andrzej T Slominski; Duane D Miller; Wei Li
Journal:  J Med Chem       Date:  2015-09-28       Impact factor: 7.446

5.  Cholecalciferol-PEG Conjugate Based Nanomicelles of Doxorubicin for Treatment of Triple-Negative Breast Cancer.

Authors:  Shallu Kutlehria; Gautam Behl; Ketan Patel; Ravi Doddapaneni; Imran Vhora; Nusrat Chowdhury; Arvind Bagde; Mandip Singh
Journal:  AAPS PharmSciTech       Date:  2017-10-10       Impact factor: 3.246

Review 6.  Vitamin D in Triple-Negative and BRCA1-Deficient Breast Cancer-Implications for Pathogenesis and Therapy.

Authors:  Janusz Blasiak; Elzbieta Pawlowska; Jan Chojnacki; Joanna Szczepanska; Michal Fila; Cezary Chojnacki
Journal:  Int J Mol Sci       Date:  2020-05-23       Impact factor: 5.923

Review 7.  Celecoxib in breast cancer prevention and therapy.

Authors:  Jieqing Li; Qiongyu Hao; Wei Cao; Jaydutt V Vadgama; Yong Wu
Journal:  Cancer Manag Res       Date:  2018-10-26       Impact factor: 3.989

8.  Differential Impact of Calcitriol and Its Analogs on Tumor Stroma in Young and Aged Ovariectomized Mice Bearing 4T1 Mammary Gland Cancer.

Authors:  Artur Anisiewicz; Agata Pawlik; Beata Filip-Psurska; Joanna Wietrzyk
Journal:  Int J Mol Sci       Date:  2020-09-02       Impact factor: 5.923

Review 9.  Vitamin D as a Potential Preventive Agent For Young Women's Breast Cancer.

Authors:  Sarah M Bernhardt; Virginia F Borges; Pepper Schedin
Journal:  Cancer Prev Res (Phila)       Date:  2021-07-09

Review 10.  Lipid metabolic reprogramming in cancer cells.

Authors:  S Beloribi-Djefaflia; S Vasseur; F Guillaumond
Journal:  Oncogenesis       Date:  2016-01-25       Impact factor: 7.485

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.